Search results
Results From The WOW.Com Content Network
Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE ) shares ended Monday's session nearly 15% higher after Canaccord Genuity said the stock's mid-September sell-off was unjustified. The Analyst Sumant ...
In the latest trading session, Zynerba Pharmaceuticals (ZYNE) closed at $5.20, marking a -0.38% move from the previous day. Zynerba Pharmaceuticals (ZYNE) Stock Sinks As Market Gains: What You ...
Zynerba Pharmaceuticals (ZYNE) closed the most recent trading day at $5, moving -0.79% from the previous trading session. ... News. 24/7 help. For premium support please call:
Website. www .vyera .com. Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017. [ 2][ 3] The company has two marketed products: Daraprim ( pyrimethamine ), for ...
Zynerba (ZYNE) announces positive top-line results from the BELIEVE 1 study evaluating the efficacy and safety of Zygel in a heterogeneous group of rare and ultra-rare epilepsies.
Spectrum Pharmaceuticals, Inc. is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology . After a deal valued at $248 million was announced in April 2023, [ 1 ] [ 2 ] Assertio Holdings announced that it had completed its acquisition of the Massachusetts -based ...
Zynerba Pharmaceuticals Inc’s (NASDAQ:ZYNE): Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The US$136.43M market-cap company announced a latest ...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F ...